Bepreve Alternatives Compared
Bepreve (bepotastine) | Ketotifen ophthalmic | Azelastine ophthalmic |
|
---|
Bepreve (bepotastine) | Ketotifen ophthalmic | Azelastine ophthalmic |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Conjunctivitis - Allergic. Bepreve may also be used for purposes not listed in this medication guide. |
Over-the-counter
Prescribed for Conjunctivitis - Allergic, Allergies. Ketotifen ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Conjunctivitis - Allergic. Azelastine ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions Conjunctivitis, Allergic
|
|||||||||||||||||||||||
More about Bepreve (bepotastine) | More about Ketotifen ophthalmic | More about Azelastine ophthalmic | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Bepreve has an average rating of 6.6 out of 10 from a total of 27 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 26% reported a negative effect. |
Ketotifen ophthalmic has an average rating of 7.5 out of 10 from a total of 24 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 21% reported a negative effect. |
Azelastine ophthalmic has an average rating of 8.6 out of 10 from a total of 5 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Bepreve side effects |
View all Ketotifen ophthalmic side effects |
View all Azelastine ophthalmic side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Bepreve prices |
View all Ketotifen ophthalmic prices |
View all Azelastine ophthalmic prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Alaway, Claritin Eye, Eye Itch Relief, Refresh Eye Itch Relief, Thera Tears Allergy Eye Itch Relief, Visine All Day Eye Itch Relief, Zaditor |
N/A |
||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
N/A |
22 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 6 drugs are known to interact with Azelastine ophthalmic:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
September 08, 2009 |
N/A |
N/A |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.